论文部分内容阅读
作者研究170例未经治疗的多发性骨髓瘤(MM)患者外周血 T 细胞亚型与疾病特征(包括生存期)的关系。病人和方法 170例未经治疗的 MM 患者,男86例,女84例,中位数年龄69岁。患者用马法兰-强的松(60%)或 VMP/VBAP(40%)交替治疗,两组的中位数生存期相似,分别为24和26个月。血清β_2微球蛋白(β_2M)水平是以放射免疫
The authors investigated the relationship between T cell subsets in peripheral blood and disease characteristics (including survival) in 170 untreated MM patients. Patients and Methods 170 untreated MM patients, 86 males and 84 females, the median age of 69 years. Patients were treated with melphalan or prednisone (60%) or VMP / VBAP (40%) alternating with median median survival of 24 and 26 months, respectively. Serum β_2 microglobulin (β_2M) levels are radioimmunoassay